RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $266,000 | -74.0% | 23,100 | -55.7% | 0.00% | -100.0% |
| Q2 2021 | $1,022,000 | -1.9% | 52,200 | +6.5% | 0.00% | 0.0% |
| Q1 2021 | $1,042,000 | +250.8% | 49,000 | +390.0% | 0.00% | – |
| Q4 2020 | $297,000 | -93.0% | 10,000 | -94.9% | 0.00% | -100.0% |
| Q3 2020 | $4,269,000 | -18.9% | 197,000 | -16.5% | 0.00% | -20.0% |
| Q2 2020 | $5,261,000 | +265.1% | 235,900 | +149.1% | 0.01% | +400.0% |
| Q1 2020 | $1,441,000 | +37.5% | 94,700 | +107.5% | 0.00% | 0.0% |
| Q4 2019 | $1,048,000 | +353.7% | 45,647 | +326.6% | 0.00% | – |
| Q3 2019 | $231,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $11,875,000 | 2.75% |
| RA Capital Management | 4,871,067 | $63,616,000 | 0.88% |
| NEA Management Company, LLC | 4,912,306 | $64,155,000 | 0.76% |
| Samsara BioCapital, LLC | 300,293 | $3,922,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,989,625 | $25,985,000 | 0.51% |
| Baker Brothers Advisors | 3,863,239 | $50,454,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 31,000 | $405,000 | 0.21% |
| Rock Springs Capital Management LP | 612,180 | $7,995,000 | 0.17% |
| GILDER GAGNON HOWE & CO LLC | 1,496,424 | $19,543,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,011,053 | $39,324,000 | 0.08% |